Description
Seeking Men and Women over the age of 18 years old with early multiple sclerosis to help determine if an investigational drug called ofatumumab is safe and effective.
Overview
We are studying the effect of an investigational drug called ofatumumab and whether it is safe and effective for participants with early relapsing forms of multiple sclerosis. This will be done through injection of the drug, blood tests, imaging, questionnaires, and other assessments.
What we're hoping for
Evaluate the safety and effectiveness ofatumumab in participants with early relapsing forms of multiple sclerosis compared to healthy controls.
Additional Information
ClinicalTrials.gov Identifier: NCT05084638